BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12879601)

  • 1. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
    Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin and catenins in invasive mammary carcinomas.
    Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
    Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
    Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
    J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
    Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of beta-catenin in in situ and invasive breast cancer.
    Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
    Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
    Park D; Kåresen R; Axcrona U; Noren T; Sauer T
    APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
    Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
    Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
    Wahed A; Connelly J; Reese T
    Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
    Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
    J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
    Qureshi HS; Linden MD; Divine G; Raju UB
    Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.